Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
901 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02461290 | Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1 | completed | — | 99 | Hoffmann-La RocheINDUSTRY | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01765569 | A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma | completed | Phase 1 | 29 | Hoffmann-La RocheINDUSTRY | 5 | Sep 23, 2015 | clinicaltrials |
| NCT02480010 | A Study of Pertuzumab in Participants With Prostate Cancer | terminated | Phase 2 | 68 | Hoffmann-La RocheINDUSTRY | 6 | Sep 18, 2015 | clinicaltrials |
| NCT02553707 | A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer | completed | Phase 4 | 182 | Hoffmann-La RocheINDUSTRY | 1 | Sep 17, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00502671 | A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. | completed | Phase 4 | 228 | Hoffmann-La RocheINDUSTRY | 1 | Sep 3, 2015 | clinicaltrials |
| NCT00817518 | A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors | completed | Phase 1 | 145 | Hoffmann-La RocheINDUSTRY | 5 | Sep 2, 2015 | clinicaltrials |
| NCT00391092 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 16 | Aug 28, 2015 | clinicaltrials |
| NCT01107418 | A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma | completed | Phase 1 | 52 | Hoffmann-La RocheINDUSTRY | 2 | Aug 26, 2015 | clinicaltrials |
| NCT02491892 | A Study of Pertuzumab in Participants With Metastatic Breast Cancer | completed | Phase 2 | 79 | Hoffmann-La RocheINDUSTRY | 8 | Aug 25, 2015 | clinicaltrials |
| NCT01183858 | A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) | completed | Phase 3 | 315 | Hoffmann-La RocheINDUSTRY | 9 | Aug 19, 2015 | clinicaltrials |
| NCT02528747 | A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate | completed | — | 582 | Hoffmann-La RocheINDUSTRY | 1 | Aug 19, 2015 | clinicaltrials |
| NCT00577031 | OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. | completed | Phase 4 | 205 | Hoffmann-La RocheINDUSTRY | 1 | Aug 18, 2015 | clinicaltrials |
| NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | completed | Phase 2 | 43 | Hoffmann-La RocheINDUSTRY | 1 | Aug 17, 2015 | clinicaltrials |
| NCT00925769 | ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer | completed | Phase 1 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Aug 7, 2015 | clinicaltrials |
| NCT00700102 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 820 | Hoffmann-La RocheINDUSTRY | 15 | Jul 30, 2015 | clinicaltrials |
| NCT01196078 | A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 4 | 114 | Hoffmann-La RocheINDUSTRY | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00269113 | A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma | completed | Phase 3 | 360 | Hoffmann-La RocheINDUSTRY | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01056510 | A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) | completed | Phase 4 | 357 | Hoffmann-La RocheINDUSTRY | 8 | Jun 25, 2015 | clinicaltrials |
| NCT01131078 | A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 306 | Hoffmann-La RocheINDUSTRY | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01287754 | A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations | completed | Phase 4 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Jun 2, 2015 | clinicaltrials |
| NCT00796757 | A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). | completed | Phase 2 | 146 | Hoffmann-La RocheINDUSTRY | 12 | May 27, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00940875 | A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 54 | Hoffmann-La RocheINDUSTRY | 1 | Apr 2, 2015 | clinicaltrials |
| NCT01230710 | A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression | completed | Phase 4 | 51 | Hoffmann-La RocheINDUSTRY | 1 | Mar 30, 2015 | clinicaltrials |
| NCT02015676 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 69 | Hoffmann-La RocheINDUSTRY | 1 | Mar 12, 2015 | clinicaltrials |
| NCT00929240 | A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 3 | 287 | Hoffmann-La RocheINDUSTRY | 11 | Mar 3, 2015 | clinicaltrials |
| NCT00531934 | A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer. | completed | Phase 2 | 147 | Hoffmann-La RocheINDUSTRY | 1 | Feb 25, 2015 | clinicaltrials |
| NCT01342965 | A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations | completed | Phase 3 | 217 | Hoffmann-La RocheINDUSTRY | 3 | Feb 24, 2015 | clinicaltrials |
| NCT00556322 | A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 27 | Feb 23, 2015 | clinicaltrials |
| NCT00556712 | A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 889 | Hoffmann-La RocheINDUSTRY | 28 | Feb 11, 2015 | clinicaltrials |
| NCT00652366 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 467 | Hoffmann-La RocheINDUSTRY | 23 | Feb 11, 2015 | clinicaltrials |
| NCT02006667 | A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer | completed | Phase 2 | 13 | Hoffmann-La RocheINDUSTRY | 1 | Feb 11, 2015 | clinicaltrials |
| NCT00709891 | Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease | completed | N/A | 47,208 | Hoffmann-La RocheINDUSTRY | 1 | Feb 9, 2015 | clinicaltrials |
| NCT01135498 | A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 90 | Hoffmann-La RocheINDUSTRY | 1 | Feb 6, 2015 | clinicaltrials |
| NCT00448136 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | completed | Phase 2 | 83 | Hoffmann-La RocheINDUSTRY | 1 | Jan 22, 2015 | clinicaltrials |
| NCT00718315 | A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | completed | Phase 3 | 201 | Hoffmann-La RocheINDUSTRY | 1 | Jan 15, 2015 | clinicaltrials |
| NCT01998919 | A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. | completed | Phase 2 | 154 | Hoffmann-La RocheINDUSTRY | 8 | Jan 13, 2015 | clinicaltrials |
| NCT00484939 | A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 280 | Hoffmann-La RocheINDUSTRY | 12 | Jan 8, 2015 | clinicaltrials |
| NCT02013206 | A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy | completed | Phase 2 | 52 | Hoffmann-La RocheINDUSTRY | 6 | Dec 19, 2014 | clinicaltrials |
| NCT01290718 | A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. | terminated | Phase 2 | 4 | Hoffmann-La RocheINDUSTRY | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | completed | Phase 2 | 75 | Hoffmann-La RocheINDUSTRY | 1 | Dec 15, 2014 | clinicaltrials |
| NCT01115491 | A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme | completed | Phase 2 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Dec 8, 2014 | clinicaltrials |
| NCT02004093 | A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer | completed | Phase 2 | 149 | Hoffmann-La RocheINDUSTRY | 9 | Dec 4, 2014 | clinicaltrials |
| NCT01998893 | A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma | completed | Phase 2 | 38 | Hoffmann-La RocheINDUSTRY | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00800202 | A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis | completed | Phase 2 | 91 | Hoffmann-La RocheINDUSTRY | 1 | Nov 19, 2014 | clinicaltrials |
| NCT00531960 | A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer. | completed | Phase 2 | 124 | Hoffmann-La RocheINDUSTRY | 13 | Nov 11, 2014 | clinicaltrials |
| NCT00559754 | A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. | completed | Phase 2 | 72 | Hoffmann-La RocheINDUSTRY | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | completed | Phase 3 | 584 | Hoffmann-La RocheINDUSTRY | 24 | Nov 5, 2014 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials